Session Details

S029 The Future is Now: A Bootcamp in Artificial Intelligence

Sat, Mar 20, 1:00 PM - 4:00 PM
3 CME Available Symposium Practice Management

DESCRIPTION

Hosted by the Augmented Intelligence Committee, this session provides foundational knowledge in artificial intelligence (AI), identifies opportunities for dermatologist collaboration in model development and implementation, and discusses how to assess and apply AI tools in practice to augment the efficiency, effectiveness, and joy of caring for patients. Core concepts, key principles, challenges, and updates on evidence, risk mitigation, and ethics will be discussed with an emphasis on accessible and actionable information. At the end of this symposium, clinicians will be empowered to critically analyze, implement and advocate for AI research and tools that are patient-centered and trustworthy.

LEARNING OBJECTIVES

1.

Define key concepts related to Artificial Intelligence (AI) and related technologies.

2.

Describe how AI, and related technologies, are developed, how they are currently used, and the potential limitations of these applications while identifying opportunities for Dermatologists to participate in the development, design, and deployment of these tools.

3.

Identify practical AI tools that can enhance clinical care, improve patient and trainee education, and increase quality of life for practicing physicians.

DIRECTOR

Shannon Wongvibulsin, MD, PhD, FAAD

Shannon Wongvibulsin, MD, PhD, FAAD

University of California, Irvine

CO-DIRECTOR

Daniel Isaac Schlessinger, MD, FAAD

Daniel Isaac Schlessinger, MD, FAAD

University of Nebraska Medical Center

SPEAKER

Jules Lipoff, MD, FAAD

Jules Lipoff, MD, FAAD

DISCLOSURES

Jules Lipoff, MD, FAAD

Amgen – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees); UpToDate – Other(Other Financial Benefit);

Daniel Isaac Schlessinger, MD, FAAD

Abbvie – Consultant (1099 relationship)(Fees); AbbVie – Investigator(Fees); Almirall – Investigator(Fees); Alumis – Investigator(Fees); Apollo Therapeutics Ltd – Investigator(Fees); Appiell Inc. – Consultant(Stock); Caliway Biopharmaceuticals Co., Ltd – Investigator(Fees); Celldex – Investigator(Fees); Croma-Pharma GmbH Austria – Advisory Board(Fees); Elf Cosmetics – Stockholder Public Company(Stock); FixMySkin – Founder(Patent royalties or other compensation for Intellectual Property Rights); Incyte Corporation – Investigator(Fees); Ipsen – Investigator(Fees); K-Health – Stockholder(No Compensation Received); LovelySkin – Employee (w-2 relationship)(Salary); LuminDx – Consultant(No Compensation Received); MoonLake Immunotherapeutics – Investigator(Fees); Nielsen BioSciences – Advisory Board(Stock), Investigator(Fees); Novartis – Investigator(Fees); Obagi Medical – Advisory Board(Fees); Oruka Therapeutics – Investigator(Fees); Pfizer Inc. – Investigator(Fees); ProTransit Nanotherapy – Advisory Board(Stock), Investigator(Fees); Sanofi – Investigator(Fees); Sun Pharmaceutical Industries Ltd. – Investigator(Fees); Takeda Pharmaceuticals USA Inc – Investigator(Fees); UCB – Investigator(Fees); Vanda Pharmaceuticals Inc. – Investigator(Fees); VeraDermics Inc. – Advisory Board(Honoraria); Verrica Pharmaceuticals Inc. – Investigator(Fees); Wontech – Speaker(Fees);

Shannon Wongvibulsin, MD, PhD, FAAD

Anatomy Mapper – Consultant (1099 relationship)(Fees); Beiersdorf – Consultant (1099 relationship)(Fees); Insight Venture Management – Consultant (1099 relationship)(Fees); VisualDx – Consultant (1099 relationship)(Honoraria);